Berliner Boersenzeitung - US panel weighs authorizing Covid vaccines for youngest children

EUR -
AED 4.112593
AFN 71.669138
ALL 90.788645
AMD 403.584889
ANG 2.004261
AOA 1026.886761
ARS 1730.125816
AUD 1.626967
AWG 2.018499
AZN 1.898968
BAM 1.953851
BBD 2.257938
BDT 139.630746
BGN 1.957279
BHD 0.423174
BIF 3350.228885
BMD 1.119833
BND 1.431154
BOB 13.536379
BRL 6.164349
BSD 1.121082
BTN 105.855122
BWP 15.358546
BYN 3.34486
BYR 21948.730437
BZD 2.254631
CAD 1.572884
CDF 2592.413635
CHF 0.91398
CLF 0.027825
CLP 1095.106913
CNY 7.489999
CNH 7.464897
COP 3625.58312
CRC 508.388442
CUC 1.119833
CUP 26.904807
CVE 110.151702
CZK 24.350217
DJF 199.630907
DKK 7.474383
DOP 67.322258
DZD 152.570958
EGP 60.270991
ERN 16.797498
ETB 183.994359
FJD 2.531983
FKP 0.830529
GBP 0.834091
GEL 2.917144
GGP 0.830529
GHS 13.076842
GIP 0.830529
GMD 83.428936
GNF 9929.875211
GTQ 8.567188
GYD 234.883652
HKD 8.775069
HNL 30.130681
HRK 7.580162
HTG 146.922162
HUF 364.716191
IDR 20314.89382
ILS 3.59355
IMP 0.830529
INR 105.468691
IQD 1699.489915
IRR 2117999.855204
ISK 136.799392
JEP 0.830529
JMD 177.81108
JOD 0.793902
JPY 176.727036
KES 145.477209
KGS 97.928631
KHR 4561.450846
KMF 493.84599
KPW 1007.849824
KRW 1523.141376
KWD 0.347775
KYD 0.934256
KZT 504.060546
LAK 25230.499556
LBP 100678.36257
LKR 372.693319
LRD 190.577384
LSL 18.370876
LTL 3.306576
LVL 0.677376
LYD 7.176843
MAD 10.925007
MDL 20.043027
MGA 5082.885427
MKD 61.549404
MMK 2351.596988
MNT 4033.608062
MOP 9.058585
MRU 45.290427
MUR 52.665738
MVR 17.307015
MWK 1943.943937
MXN 21.013656
MYR 4.54596
MZN 71.568673
NAD 18.371532
NGN 1505.481108
NIO 41.257932
NOK 10.448884
NPR 169.371573
NZD 2.013701
OMR 0.430574
PAB 1.121072
PEN 3.861449
PGK 5.106861
PHP 70.608858
PKR 310.053613
PLN 4.40375
PYG 6907.111508
QAR 4.097785
RON 5.336121
RSD 117.64746
RUB 91.267205
RWF 1651.338367
SAR 4.203464
SBD 9.016581
SCR 15.530541
SDG 673.57461
SEK 11.01693
SGD 1.433806
SHP 0.834886
SLE 25.654803
SLL 23482.34691
SOS 640.655351
SRD 42.057597
STD 23178.286007
STN 24.475372
SVC 9.809086
SYP 14560.070726
SZL 18.364521
THB 37.54073
TJS 10.341648
TMT 3.930614
TND 3.340464
TOP 2.696289
TRY 56.152239
TTD 7.592326
TWD 36.884021
TZS 2966.696034
UAH 50.924158
UGX 4534.437294
USD 1.119833
UYU 45.154765
UZS 13377.539063
VES 1000.872181
VND 28676.1283
VUV 133.835028
WST 3.111473
XAF 655.957
XAG 0.021762
XAU 0.000276719297
XCD 3.026405
XCG 2.020367
XDR 0.79178
XOF 655.957
XPF 119.331742
YER 264.476607
ZAR 18.50484
ZMK 10079.847437
ZMW 22.729129
ZWL 360.585829
SSP 6433.66131
MXV 2.364121
  • CMSD

    -0.1200

    19.81

    -0.61%

  • JRI

    0.0000

    10.77

    0%

  • BCC

    -1.8200

    74.15

    -2.45%

  • CMSC

    -0.2228

    19.53

    -1.14%

  • BCE

    0.2000

    20.34

    +0.98%

  • RIO

    0.0100

    94.17

    +0.01%

  • AZN

    -2.7400

    161.47

    -1.7%

  • GSK

    -1.1800

    48.17

    -2.45%

  • RBGPF

    0.0000

    65

    0%

  • NGG

    0.8800

    75.82

    +1.16%

  • RYCEF

    -0.7300

    19.08

    -3.83%

  • BTI

    -0.4500

    54.4

    -0.83%

  • BP

    0.4700

    43.99

    +1.07%

  • RELX

    -0.0600

    33.18

    -0.18%

  • VOD

    -0.1800

    16.15

    -1.11%

US panel weighs authorizing Covid vaccines for youngest children
US panel weighs authorizing Covid vaccines for youngest children / Photo: Frederic J. BROWN - AFP/File

US panel weighs authorizing Covid vaccines for youngest children

After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.

Text size:

Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.

Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."

Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.

Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.

They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.

But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.

There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.

Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.

Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.

Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."

(S.G.Stein--BBZ)